Lung-targeted delivery system of curcumin loaded gelatin microspheres

Drug Delivery

Volumn 18, Issue 8, 2011, Pages 545-554

  Cao, Fengliang ^b   Ding, Buyun ^a   Sun, Min ^a   Guo, Chenyu ^a   Zhang, Lin ^a   Zhai, Guangxi ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong University   (China)

Author keywords

Curcumin; Emulsification linkage; Gelatin; Lung targeted; Microspheres

Indexed keywords

CURCUMIN; GELATIN; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG RELEASE; DRUG STABILITY; DRUG TISSUE LEVEL; EMULSION; ENCAPSULATION; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; IN VITRO STUDY; LUNG; LUNG PARENCHYMA; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMAL STRUCTURES; ANIMALS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CURCUMIN; DRUG DELIVERY SYSTEMS; EMULSIONS; FORMALDEHYDE; GELATIN; GLUTARAL; HEXOSES; INJECTIONS, INTRAVENOUS; LUNG; LUNG NEOPLASMS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MINERAL OIL; PARTICLE SIZE; POWDERS; RABBITS; RHEOLOGY; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; TISSUE DISTRIBUTION; TRANSITION TEMPERATURE;

EID: 82055208336     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2011.595842     Document Type: Article

References (42)

1. Anand P, Kunnumakkara AB, Newman RA, et al. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm. 4(6): 807-818.
2. Anand P, Sundaram C, Jhurani S, et al. (2008). Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Lett. 267(1): 133-164.
3. Batycky RP, Hanes J, Langer R, et al. (1997). A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci. 86(12):1464-1477. (Pubitemid 28018331)
4. Dinarvand R, Mahmoodi S, Farboud E, Salehi M, Atyabi F. (2005). Preparation of gelatin microspheres containing lactic acid-effect of cross-linking on drug release. Acta Pharm. 55(1): 57-67. (Pubitemid 40562619)
5. Esposito E, Cortesi R, Nastruzzi C. (1996). Gelatin microsphere: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials. 17(20): 2009-2020. (Pubitemid 26328942)
6. Esposito E, Pastesini C, Cortesi R, et al. (1995). Controlled release of 1-/3-D-arabinofuranosylcytosine (ara-C) from hydrophilic gelatin microspheres: in vitro studies. Int. J. Pharm. 117: 151-158.
7. Freiberg S, Zhu XX. (2004). Polymer microspheres for controlled drug release. Int. J. Pharm. 282(1-2): 1-18. (Pubitemid 39178480)
8. Gallo JM, Gupta PK, Hung CT et al. (1989). Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat. J Pharm Sci. 78(3): 190-194. (Pubitemid 19079840)
9. Ghaderi R, Struesson C, Carlfors J. (1996). Effect of preparative parameters on the characteristics of poly (d,l-lactideco-glocolide) microspheres made by the double emulsion method. Int. J. Pharm. 141: 205-216. (Pubitemid 26302926)
10. Ikada Y, Tabata Y., Protein release from gelatin matrices. (1998). Adv Drug Deliv Rev. 31: 287-301. (Pubitemid 28191870)
11. Illum L, Davis SS, Wilson CG, et al. (1982). Blood clearance and organ deposition of intravenously administered colloidal particles: The effects of particle size, nature and shape. Int. J. Pharm. 12: 135-146. (Pubitemid 12037337)
12. Iwanaga K, Yabuta T, Kakemi M, et al. (2003). Usefulness of microspheres composed of gelatin with various cross-linking density. J. Microencapsul. 20(6): 767-776. (Pubitemid 37406799)
13. Jain A, Gupta Y, Jain SK. (2007). Potential of calcium pectinate beads for target specific drug release to colon. J Drug Target. 15(4): 285-294. (Pubitemid 47177036)
14. Jemal A, Siegel R, Ward E, et al. (2007). Cancer statistics, 2007. CA Cancer J. Clin. 57(1): 43-66.
15. Kanke M, Simmons GH, Weiss DL, et al. (1980). Clearance of 141C3-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs. J Pharm Sci. 69(7):755-762. (Pubitemid 11237850)
16. Kawai K, Suzuki S, Tabata Y, et al. (2000). Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials. 21(5): 489-499. (Pubitemid 30067585)
17. Lee J, Im YH, Jung HH, et al. (2005). Curcumin inhibits interferonalpha induced NF-kappa B and COX-2 in human A549 non-small cell lung cancer cells. Biochem and Biophys Res Communs. 334(2): 313-318. (Pubitemid 40982371)
18. Lim ST, Forbes B, Martin GP, et al. (2001). In vivo and in vitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate. AAPS Pharm Sci Tech. 2 (4): E20.
19. Lu B, Zhang JQ, Yang H. (1999). Studies on lung targeting gelatin microspheres of carboplatin. Acta Pharmaceutica Sinica. 34: 786-789.
20. Lu B. (1998).New Techniques and New Dosage Forms of Drugs. Beijing, China: Peoples Health Publishing House.
21. Lv Q, Yu A, Xi Y, et al. (2009). Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int. J. Pharm. 372(1-2): 191-198.
22. Ma ZS, Shayeganpour A, Brocks DR, et al. (2007). High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. J. Biomed Chromatogr. 21(5): 546-552. (Pubitemid 46736190)
23. Maheshwari RK, Singh AK, Gaddipati J, et al. (2006). Multiple biological activities of curcumin: A short review. Life Sci. 78(18): 2081-2087.
24. Mathew ST, Devi SG, KV S. (2007). Formulation and Evaluation of Ketorolac Tromethamine-loaded Albumin Microspheres for Potential Intramuscular Administration. AAPS Pharm Sci Tech. 8 (1): E14.
25. Menon LG, Kuttan R, Kuttan G. (1995). Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 95(1-2): 221-225.
26. Mladenovska K, Kumbaradzi E, Dodov G, et al. (2002). Biodegradation and drug release studies of BSA loaded gelatin microspheres. Int. J. Pharm. 242(1-2): 247-249.
27. Mu L, Feng SS. (2001). Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J. Control Release. 76(3): 239-254. (Pubitemid 32913433)
28. Muvaffak A, Gurhan I, Hasirci N. (2004). Prolonged cytotoxic effect of colchicine released from biodegradable microspheres. J Biomed Mater Res B Appl Biomater. 71(2): 295-304. (Pubitemid 39463764)
29. Nanji, AA, Jakelainen, K, Fotouhinia, M, et al. (2001). Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin and chemokines. Am J Physiol Gastrointest Liver Physiol. 281(6): 1348-1356.
30. Paharia A, Yadav AK, Rai G, Jain SK, Pancholi SS, Agrawal GP. (2007). Eudragit-coated Pectin Microspheres of 5-Fluorouracil for Colon Targeting. AAPS Pharm Sci Tech. 8(1): E12.
31. Pan MH, Huang TM, Lin JK. (1999). Biotransformation of Curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 27(4): 486-494.
32. Prior S, Gamazo C, Irache JM, et al. (2000). Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Int. J. Pharm. 196(1):115-125. (Pubitemid 30089520)
33. Radhakrishna Pillai G, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E. (2004). Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett. 208(2): 163-170. (Pubitemid 38624157)
34. Rahman Z, Kohli K, Khar RK, Ali M, Charoo NA, Shamsher AA. (2006). Characterization of 5-Fluorouracil Microspheres for Colonic Delivery. J. AAPS Pharm Sci Tech. 7(2): E47.
35. Raouf G, Cecilia S, Johan C. (1996). Effect of preparative parameters on the characteristics of poly (d,l-lactideco-glocolide) microspheres made by the double emulsion method. Int. J. Pharm. 4: 205-216.
36. Sahu A, Bora U, Kasoju N, Goswami P. (2008). Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomaterialia. 4 (6): 1752-1761.
37. Sharma RA, Steward WP, Gescher A. (2007). Pharmacokinetics and pharmacodynamics of curcumin. Advances in Experimental Medicine and Biology. 595: 453-470.
38. Tabata Y, Nagano A, Ikada Y. (1999). Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng. 5(2): 127-138. (Pubitemid 29196555)
39. Wang SN, Deng YH, Zheng SH, et al. (2003). Studies on preparation of ciprofloxacin liposomes and its tissue distribution in mice. Chin Pharm J. 38: 274-277.
40. Wang YJ, Pan MH, Cheng AL, et al. (1997). Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 15(12): 1867-1876.
41. Yoshioka T, Hashlda M, Muranishi et al. (1981). Specific delivery of mitomyein C to the liver, spleen and lung: nano and mierospherical carriers of gelatin. Int. J. Parm. 8: 131-139.
42. Zeng FB, Lu B, Yang H, et al. (1996). Studies on gelatin microsphere loaded ligustrazine hydrochloride for lung targeting. Yao Xue Xue Bao. 31(2): 132-137. (Pubitemid 126436210)